Publications by authors named "Ola Caster"

Claim this Profile
D
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations.
Ola Caster, Yasunori Aoki, Lucie M Gattepaille, Birgitta Grundmark

Drug Saf· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR.
John van Stekelenborg, Johan Ellenius, Simon Maskell, Tomas Bergvall, Ola Caster

Drug Saf· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century.
Sarah Watson, Ola Caster, Paula A Rochon, Hester den Ruijter

EClinicalMedicine· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project.
Ola Caster, Juergen Dietrich, Marie-Laure Kürzinger, Magnus Lerch, Simon Maskell

Drug Saf· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study.
Ingrid Oosterhuis, Henric Taavola, Philip M Tregunno, Petar Mas, Sara Gama, Ola Caster

Drug Saf· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database.
Leàn Rolfes, Florence van Hunsel, Ola Caster, Henric Taavola, Katja Taxis

Br J Clin Pharmacol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use.
Ola Caster, Lovisa Sandberg, Tomas Bergvall, Sarah Watson, G Niklas Norén

Pharmacoepidemiol Drug Saf· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase.
Rebecca E Chandler, Kristina Juhlin, Jonas Fransson, Ola Caster, I Ralph Edwards

Drug Saf· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome.
Yen S Low, Ola Caster, Tomas Bergvall, Denis Fourches, Xiaoling Zang

J Am Med Inform Assoc· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
Ola Caster, I Ralph Edwards

BMC Neurol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' reply to Harpaz et al. comment on: "Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance".
G Niklas Norén, Ola Caster, Kristina Juhlin, Marie Lindquist

Drug Saf· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance.
G Niklas Norén, Ola Caster, Kristina Juhlin, Marie Lindquist

Drug Saf· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank.
Ola Caster, Kristina Juhlin, Sarah Watson, G Niklas Norén

Drug Saf· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance.
Ola Caster, Anita Conforti, Ermelinda Viola, I Ralph Edwards

Eur J Clin Pharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computing limits on medicine risks based on collections of individual case reports.
Ola Caster, G Niklas Norén, I Ralph Edwards

Theor Biol Med Model· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative benefit-risk assessment using only qualitative information on utilities.
Ola Caster, G Niklas Norén, Love Ekenberg, I Ralph Edwards

Med Decis Making· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and evaluation of triage algorithms for early discovery of adverse drug interactions.
Johanna Strandell, Ola Caster, Johan Hopstadius, I Ralph Edwards, G Niklas Norén

Drug Saf· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose variations associated with formulations of NSAID prescriptions for children: a descriptive analysis of electronic health records in the UK.
Kristina Star, Ola Caster, Andrew Bate, I Ralph Edwards

Drug Saf· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Earlier discovery of pregabalin's dependence potential might have been possible.
Ola Caster, I Ralph Edwards, G Niklas Norén, Marie Lindquist

Eur J Clin Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.
Johanna Strandell, Ola Caster, Andrew Bate, Niklas Norén, I Ralph Edwards

Drug Saf· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflections on attribution and decisions in pharmacovigilance.
Ola Caster, I Ralph Edwards

Drug Saf· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.
Jakob Ribbing, Joakim Nyberg, Ola Caster, E Niclas Jonsson

J Pharmacokinet Pharmacodyn· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis